久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/30 | 3,850 | 3,850 | 3,725 | 3,775 | -5 | -0.1% | 200,800 |
| 2022/03/29 | 3,780 | 3,780 | 3,720 | 3,780 | -5 | -0.1% | 178,900 |
| 2022/03/28 | 3,870 | 3,870 | 3,760 | 3,785 | -75 | -1.9% | 148,200 |
| 2022/03/25 | 3,860 | 3,860 | 3,785 | 3,860 | +50 | +1.3% | 220,400 |
| 2022/03/24 | 3,830 | 3,860 | 3,750 | 3,810 | -95 | -2.4% | 245,700 |
| 2022/03/23 | 3,795 | 3,905 | 3,765 | 3,905 | +155 | +4.1% | 262,000 |
| 2022/03/22 | 3,785 | 3,785 | 3,715 | 3,750 | ±0 | ±0% | 215,700 |
| 2022/03/18 | 3,810 | 3,820 | 3,700 | 3,750 | -50 | -1.3% | 372,400 |
| 2022/03/17 | 3,785 | 3,810 | 3,735 | 3,800 | +75 | +2% | 198,000 |
| 2022/03/16 | 3,750 | 3,765 | 3,710 | 3,725 | +25 | +0.7% | 143,600 |
| 2022/03/15 | 3,610 | 3,720 | 3,600 | 3,700 | +80 | +2.2% | 146,400 |
| 2022/03/14 | 3,600 | 3,670 | 3,600 | 3,620 | +15 | +0.4% | 141,600 |
| 2022/03/11 | 3,640 | 3,645 | 3,585 | 3,605 | -105 | -2.8% | 187,200 |
| 2022/03/10 | 3,645 | 3,715 | 3,595 | 3,710 | +135 | +3.8% | 308,500 |
| 2022/03/09 | 3,560 | 3,605 | 3,490 | 3,575 | +45 | +1.3% | 245,700 |
| 2022/03/08 | 3,430 | 3,565 | 3,425 | 3,530 | +65 | +1.9% | 247,200 |
| 2022/03/07 | 3,465 | 3,485 | 3,420 | 3,465 | -55 | -1.6% | 210,900 |
| 2022/03/04 | 3,550 | 3,570 | 3,505 | 3,520 | -65 | -1.8% | 174,700 |
| 2022/03/03 | 3,550 | 3,590 | 3,520 | 3,585 | +70 | +2% | 174,200 |
| 2022/03/02 | 3,585 | 3,595 | 3,505 | 3,515 | -105 | -2.9% | 214,700 |
| 2022/03/01 | 3,650 | 3,665 | 3,605 | 3,620 | -40 | -1.1% | 205,200 |
| 2022/02/28 | 3,540 | 3,660 | 3,540 | 3,660 | +120 | +3.4% | 250,200 |
| 2022/02/25 | 3,600 | 3,620 | 3,515 | 3,540 | -60 | -1.7% | 241,900 |
| 2022/02/24 | 3,535 | 3,600 | 3,505 | 3,600 | +35 | +1% | 340,200 |
| 2022/02/22 | 3,615 | 3,615 | 3,550 | 3,565 | -80 | -2.2% | 172,800 |
| 2022/02/21 | 3,690 | 3,695 | 3,635 | 3,645 | -105 | -2.8% | 113,900 |
| 2022/02/18 | 3,660 | 3,755 | 3,660 | 3,750 | +25 | +0.7% | 164,500 |
| 2022/02/17 | 3,830 | 3,830 | 3,700 | 3,725 | -100 | -2.6% | 190,800 |
| 2022/02/16 | 3,780 | 3,825 | 3,740 | 3,825 | +70 | +1.9% | 247,100 |
| 2022/02/15 | 3,690 | 3,755 | 3,680 | 3,755 | +75 | +2% | 308,400 |
| 2022/02/14 | 3,600 | 3,695 | 3,585 | 3,680 | +10 | +0.3% | 152,500 |
| 2022/02/10 | 3,720 | 3,720 | 3,665 | 3,670 | -20 | -0.5% | 199,700 |
| 2022/02/09 | 3,665 | 3,700 | 3,605 | 3,690 | +15 | +0.4% | 215,400 |
| 2022/02/08 | 3,680 | 3,705 | 3,640 | 3,675 | -5 | -0.1% | 182,900 |
| 2022/02/07 | 3,605 | 3,685 | 3,580 | 3,680 | +45 | +1.2% | 218,100 |
| 2022/02/04 | 3,600 | 3,650 | 3,570 | 3,635 | -25 | -0.7% | 251,600 |
| 2022/02/03 | 3,580 | 3,665 | 3,565 | 3,660 | +25 | +0.7% | 283,700 |
| 2022/02/02 | 3,530 | 3,635 | 3,530 | 3,635 | +130 | +3.7% | 278,600 |
| 2022/02/01 | 3,520 | 3,550 | 3,490 | 3,505 | +30 | +0.9% | 232,700 |
| 2022/01/31 | 3,475 | 3,505 | 3,435 | 3,475 | +45 | +1.3% | 216,500 |
| 2022/01/28 | 3,400 | 3,455 | 3,400 | 3,430 | +95 | +2.8% | 244,400 |
| 2022/01/27 | 3,460 | 3,465 | 3,335 | 3,335 | -120 | -3.5% | 340,000 |
| 2022/01/26 | 3,550 | 3,565 | 3,455 | 3,455 | -135 | -3.8% | 286,400 |
| 2022/01/25 | 3,575 | 3,600 | 3,535 | 3,590 | -10 | -0.3% | 232,700 |
| 2022/01/24 | 3,505 | 3,600 | 3,475 | 3,600 | +75 | +2.1% | 283,100 |
| 2022/01/21 | 3,410 | 3,525 | 3,405 | 3,525 | +80 | +2.3% | 267,200 |
| 2022/01/20 | 3,360 | 3,460 | 3,360 | 3,445 | +45 | +1.3% | 324,100 |
| 2022/01/19 | 3,415 | 3,450 | 3,390 | 3,400 | -70 | -2% | 290,900 |
| 2022/01/18 | 3,565 | 3,620 | 3,470 | 3,470 | -120 | -3.3% | 381,700 |
| 2022/01/17 | 3,650 | 3,660 | 3,575 | 3,590 | -45 | -1.2% | 343,000 |
801～
850
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 400,200円 | +5.8% | +1.2% | 3.00% | 13.27倍 | 1.06倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ロート | 206,800円 | +8.4% | +0.2% | 2.03% | 15.03倍 | 1.80倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 住友ファーマ | 89,500円 | -11.0% | +206.6% | 0.00% | 8.89倍 | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 350,300円 | +3.8% | -19.9% | 3.88% | 11.38倍 | 0.87倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 313,300円 | +8.0% | -15.3% | 3.96% | 8.80倍 | 0.85倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
